compounded semaglutide crackdown news november 2025 GLP-1s: Why doctors worry and the FDA is cracking down Drug compounders sue FDA over

In STEP-1, participants taking semaglutide 2.4mg weekly lost an average of 14.9% of body weight over 68 weeks

5 As well, GLP-1 medications may lead to injection site reactions or affect the absorption of other oral medications due to delayed gastric emptying

For many people, the idea of self-injecting can seem daunting, but semaglutide injections are specifically designed to be easy and nearly painless, even for beginners

You are traveling internationally and need documentation

Understanding these storage requirements helps patients protect their investment and achieve consistent weight loss results

Personalized care means having a provider who understands your history and a support system that celebrates your progress